Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
The Asia-Pacific region is expected to dominate the global nutraceutical products market from 2025 to 2030, fuelled by a mix of demographic, economic, and regulatory changes
The Global Nutraceutical Product Market size was valued at around $ 591.1 billion in 2024 and is expected to reach roughly $ 912.25 billion by 2030, growing at a rate of about 7.50 per cent per year from 2025 to 2030, according to a recent report by MarkNtel Advisors.
This growth is largely due to people becoming more health-conscious and showing a greater interest in functional foods. The rise in chronic illnesses and stricter government rules on food fortification also play a significant role in driving market demand. Customisation is becoming increasingly popular as more consumers recognise the availability of personalised nutraceuticals that meet their unique health needs. Many people are looking for personalised supplements, diet plans, and fitness routines that can assist them in achieving better health.
Additionally, there’s a growing focus on medical nutrition, especially with dietary supplements being used to address issues like heart disease and malnutrition. The ageing population, rising healthcare costs, and changing lifestyles, combined with investments from established companies in new product development, are expected to boost the market further. Overall, the nutraceuticals market is evolving to provide better solutions for people’s health needs.
The Asia-Pacific region is expected to dominate the global nutraceutical products market from 2025 to 2030, fuelled by a mix of demographic, economic, and regulatory changes impacting consumer behaviour. The middle class is rapidly growing in countries like China, India, Indonesia, and Vietnam, leading to increased health awareness and higher disposable incomes. This shift encourages greater spending on preventive healthcare, functional foods, dietary supplements, and fortified drinks. Furthermore, heightened awareness surrounding immunity, gut health, and chronic disease prevention post-COVID-19 is driving the long-term adoption of nutraceuticals in the region.